---

**UNITED STATESSECURITIES AND EXCHANGE COMMISSION** Washington, D.C. 20549

FORM 10-QSB/AAmendment No. 1

**x****** Quarterly
  Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2004

** ̈**  Transition
  Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period __________ to __________

Commission File Number: 000-29803

EYI INDUSTRIES, INC.
  (Exact name of small business issuer as specified in its charter)

|NEVADA                                          | 88-0407078                       
|----------------------------------------------- | ---------------------------------
|(State or other jurisdiction of                 | (IRS Employer Identification No.)
|incorporation or organization)                  |                                  
|                                                |                                  
|3960 Howard Hughes Parkway, Suite 500           |                                  
|Las Vegas, Nevada                               | 89109                            
|(Address of principal executive offices)        | (Zip Code)                       
|                                                |                                  
|Issuer's telephone number, including area code: | (702) 296-8034                   

NOT APPLICABLE 
  (Former name, former address and former fiscal year end, 
  if changed since last report)

Check whether the issuer (1) filed all reports required to
  be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
  the preceding 12 months (or for such shorter period that the issuer was required
  to file such reports), and (2) has been subject to such filing requirements
  for the past 90 days: Yes **x******No
  ** ̈**

State the number of shares outstanding of each of the issuer's
  classes of common stock, as of the latest practicable date: 160,626,594shares of common stock issued and outstanding as of August 10, 2004.

Transitional Small Business Disclosure Format (check one):
  Yes ** ̈**    No  **x******

---

Explanatory
  Note

This Amended Quarterly Report on Form 10-QSB/A dated August 19, 2004 is being
  filed to:

| | (i)   | correct a typographical error in respect of the registrant’s
        compensation expenses disclosed under the heading “Item 2. Management’s
        Discussion and Analysis or Plan of Operation – Results of Operations”
        to reflect compensation expenses incurred for the six months ended June
        30, 2004;                                                 
| | ----- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |       |                                                                                                                                                                                                                                                                                                                                                                              
| | (ii)  | remove the final subsequent event referred to in
        Note 10 to the accompanying interim unaudited financial statements for
        the three months ended June 30, 2004, which was inadvertently included
        in the Form 10-QSB filed on August 18, 2004 and which is referenced in
        Note 4 and Note 7 to the accompanying interim financial statements; and
| |       |                                                                                                                                                                                                                                                                                                                                                                              
| | (iii) | make minor corrections to the accompanying interim
        unaudited financial statements for the three months ended June 30, 2004
        due to a recalculation of minority interest, and make the corresponding
        changes to the disclosure under the heading “Item 2. Management’s
        Discussion and Analysis or Plan of Operation”.                          

Other than the foregoing items and conforming changes related
  thereto, no part of the Quarterly Report on Form 10-QSB filed on August 18,
  2004 is being amended, and the filing of this Amended Quarterly Report on Form
  10-QSB/A should not be understood to mean that any other statements contained
  therein are untrue or incomplete as of any date subsequent to August 18, 2004.



PART 1 - FINANCIAL INFORMATION

ITEM 1.              FINANCIAL
  STATEMENTS



2

---

EYI INDUSTRIES, INC.

CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2004



F-1

---

EYI INDUSTRIES, INC.CONSOLIDATED BALANCE SHEETS

|                                                            |   | June 30, 2004 |   |   | December 31, 2003 |  
|----------------------------------------------------------- | - | ------------- | - | - | ----------------- | -
|                                                            |   | (Unaudited)   |   |   |                   |  
|ASSETS                                                      |   |               |   |   |                   |  
|                                                           
|CURRENT ASSETS                                              |   |               |   |   |                   |  
|Cash                                                        | $ | 60,524        |   | $ | 52,075            |  
|Restricted cash                                             |   | 210,314       |   |   | 223,682           |  
|Accounts receivable                                         |   | 38,519        |   |   | 52,323            |  
|Related party receivables                                   |   | 4,995         |   |   | 5,465             |  
|Prepaid expenses                                            |   | 1,056,084     |   |   | 28,600            |  
|Inventory                                                   |   | 208,318       |   |   | 254,367           |  
|TOTAL
      CURRENT ASSETS                                  |   | 1,578,754     |   |   | 616,512           |  
|                                                           
|OTHER ASSETS                                                |   |               |   |   |                   |  
|Property, plant and
      equipment, net                    |   | 95,106        |   |   | 143,439           |  
|Deferred offering costs                                     |   | 390,000       |   |   | -                 |  
|TOTAL
      OTHER ASSETS                                    |   | 485,106       |   |   | 143,439           |  
|                                                           
|INTANGIBLE ASSETS                                           |   | 17,641        |   |   | 19,801            |  
|                                                           
|TOTAL ASSETS                                                | $ | 2,081,501     |   | $ | 779,752           |  
|                                                           
|LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)              |   |               |   |   |                   |  
|                                                           
|CURRENT LIABILITIES                                         |   |               |   |   |                   |  
|Bank indebtedness                                           | $ | 42,819        |   | $ | 259,977           |  
|Accounts payable and
      accrued liabilities              |   | 719,622       |   |   | 836,751           |  
|Accounts payable -
      related parties                    |   | 822,789       |   |   | 779,367           |  
|Customer deposits                                           |   | 6,250         |   |   | 6,250             |  
|TOTAL
      CURRENT LIABILITIES                             |   | 1,591,480     |   |   | 1,882,345         |  
|                                                           
|COMMITMENTS AND CONTINGENCIES                               |   | -             |   |   | -                 |  
|                                                           
|MINORITY INTEREST IN SUBSIDIARY                             |   | 452,879       |   |   | 468,877           |  
|                                                           
|STOCKHOLDERS' EQUITY (DEFICIT)                              |   |               |   |   |                   |  
|Preferred stock, $0.001
      par value; 10,000,000 shares  |   |               |   |   |                   |  
|authorized,
      no shares issued and outstanding          |   |               |   |   |                   |  
|Common stock, $0.001
      par value; 537,278,000 shares    |   |               |   |   |                   |  
|authorized,
      161,540,148 and 148,180,670 shares issued |   |               |   |   |                   |  
|and outstanding,
      respectively                         |   | 161,540       |   |   | 148,181           |  
|Discount on common
      stock                              |   | (53,598       | ) |   | (53,598           | )
|Additional paid-in
      capital                            |   | 2,646,802     |   |   | 827,972           |  
|Stock warrants                                              |   | 935,241       |   |   | 128,385           |  
|Subscription receivable                                     |   | (15,000       | ) |   | -                 |  
|Accumulated deficit                                         |   | (3,637,843    | ) |   | (2,622,410        | )
|TOTAL
      STOCKHOLDERS' EQUITY (DEFICIT)                  |   | 37,142        |   |   | (1,571,470        | )
|                                                           
|TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)        | $ | 2,081,501     |   | $ | 779,752           |  

The accompanying condensed notes are an integral part of these
  financial statements.

F-2

---

EYI INDUSTRIES, INC.CONSOLIDATED STATEMENTS OF OPERATIONS

|                                                |   | Three Months Ended June 30, |   |   | Six Months Ended June 30, |  
|----------------------------------------------- | - | --------------------------- | - | - | ------------------------- | -
|                                                |   | 2004                        |   |   | 2003                      |  
|                                                |   | (Unaudited)                 |   |   | (Unaudited)               |  
|                                               
|REVENUE                                         | $ | 1,965,737                   |   | $ | 2,775,506                 |  
|                                               
|COST OF GOODS SOLD                              |   | 1,343,919                   |   |   | 1,750,595                 |  
|                                               
|GROSS PROFIT                                    |   | 621,818                     |   |   | 1,024,911                 |  
|                                               
|OPERATING EXPENSES                              |   |                             |   |   |                           |  
|Consulting fees                                 |   | 205,373                     |   |   | 154,770                   |  
|Legal and professional                          |   | 198,497                     |   |   | 27,480                    |  
|Customer service                                |   | 94,745                      |   |   | 288,240                   |  
|Finance and administration                      |   | 49,801                      |   |   | 289,460                   |  
|Sales and marketing                             |   | 105,952                     |   |   | 56,968                    |  
|Telecommunications                              |   | 151,036                     |   |   | 196,126                   |  
|Wages and benefits                              |   | 307,648                     |   |   | 185,820                   |  
|Warehouse expense                               |   | 254,896                     |   |   | 26,272                    |  
|TOTAL OPERATING EXPENSES                        |   | 1,367,948                   |   |   | 1,225,136                 |  
|                                               
|OPERATING LOSS                                  |   | (746,130                    | ) |   | (200,225                  | )
|                                               
|OTHER INCOME (EXPENSES)                         |   |                             |   |   |                           |  
|Interest and other income                       |   | (3,173                      | ) |   | 8,947                     |  
|Interest expense                                |   | 12,511                      |   |   | (9,076                    | )
|Foreign currency gain/(discount)                |   | (9,906                      | ) |   | 11,689                    |  
|TOTAL OTHER INCOME (EXPENSES)                   |   | (568                        | ) |   | 11,560                    |  
|                                               
|NET LOSS BEFORE TAXES                           |   | (746,698                    | ) |   | (188,665                  | )
|                                               
|PROVISION FOR INCOME TAXES                      |   | -                           |   |   | -                         |  
|                                               
|NET LOSS BEFORE ALLOCATION TO MINORITY INTEREST |   | (746,698                    | ) |   | (188,665                  | )
|                                               
|ALLOCATION OF LOSS TO MINORITY INTEREST         |   | 8,238                       |   |   | -                         |  
|                                               
|NET LOSS                                        | $ | (738,460                    | ) |   | (188,665                  | )
|                                               
|BASIC AND DILUTED                               |   |                             |   |   |                           |  
|NET LOSS PER COMMON SHARE                       | $ | nil                         |   |   | nil                       |  
|                                               
|WEIGHTED AVERAGE NUMBER OF                      |   |                             |   |   |                           |  
|COMMON STOCK SHARES OUTSTANDING                 |   |                             |   |   |                           |  
|FOR BASIC AND DILUTED CALCULATION               |   | 154,362,296                 |   |   | 118,045,603               |  

The accompanying condensed notes are an integral part of these
  financial statements.

F-3

---

EYIINDUSTRIES,INC.CONSOLIDATEDSTATEMENTOFSTOCKHOLDERS'EQUITY(DEFICIT)

|                                                        | Common Stock |  |   | Additional |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|------------------------------------------------------- | ------------ |  | - | ---------- |  | - | --------- |  | - | ------------ | - | - | ------------ | - | - | -------- |  | - | ----------- | -
|                                                        | Number of    |  |   |            |  |   | Paid-in   |  |   | Discount on  |   |   | Subscription |   |   | Option/  |  |   | Accumulated |  
|                                                        | Shares       |  |   | Amount     |  |   | Capital   |  |   | Common Stock |   |   | Receivable   |   |   | Warrants |  |   | Deficit     |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Stock issued for cash on June 21, 2002                  | 23,026,200   |  | $ | 23,026     |  | $ | 6,974     |  | $ | -            |   | $ | -            |   | $ | -        |  | $ | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Contribution of assets, liabilities and                 |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|subsidiaries acquired at June 30, 2002                  | 92,104,800   |  |   | 92,105     |  |   | -         |  |   | (53,598      | ) |   |              |   |   | -        |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Net loss for period ended June 30, 2002                 | -            |  |   | -          |  |   | -         |  |   | -            |   |   |              |   |   | -        |  |   | (7,967      | )
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Balance, June 30, 2002                                  | 115,131,000  |  |   | 115,131    |  |   | 6,974     |  |   | (53,598      | ) |   | -            |   |   | -        |  |   | (7,967      | )
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Shares issued for cash in private                       |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|placement for $1.50 per share,                          |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|net of prorata share of private placement               |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|fees of $61,206                                         | 2,914,603    |  |   | 2,915      |  |   | 477,307   |  |   | -            |   |   | -            |   |   | -        |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Net loss for fiscal year ended                          |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|June 30, 2003                                           | -            |  |   | -          |  |   | -         |  |   | -            |   |   | -            |   |   | -        |  |   | (1,644,456  | )
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Balance, June 30, 2003                                  | 118,045,603  |  |   | 118,046    |  |   | 484,281   |  |   | (53,598      | ) |   | -            |   |   | -        |  |   | (1,652,423  | )
|Recapitalization and share exchange (restated)          | 30,135,067   |  |   | 30,135     |  |   | 343,691   |  |   | -            |   |   | -            |   |   | 128,385  |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Net loss for fiscal year ended                          |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|December 31, 2003                                       | -            |  |   | -          |  |   | -         |  |   | -            |   |   | -            |   |   | -        |  |   | (969,987    | )
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Balance, December 31, 2003 (restated)                   | 148,180,670  |  |   | 148,181    |  |   | 827,972   |  |   | (53,598      | ) |   | -            |   |   | 128,385  |  |   | (2,622,410  | )
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Common stock issued at $0.20 including                  |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|warrants less expenses of $28,715                       | 1,466,455    |  |   | 1,466      |  |   | 146,930   |  |   | -            |   |   | -            |   |   | 70,844   |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Stock issued at $0.165 per share for cashless           |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|exercise of options in form of foregone debt            | 3,200,000    |  |   | 3,200      |  |   | 524,800   |  |   | -            |   |   | -            |   |   | -        |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Stock issued for exercise of options at $0.20 per share |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|in lieu of payment of legal fees                        | 300,000      |  |   | 300        |  |   | 59,700    |  |   | -            |   |   | -            |   |   | -        |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Stock issued at $0.165 per share for cash and           |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|promissory note for exercise of options                 | 1,000,000    |  |   | 1,000      |  |   | 164,000   |  |   | -            |   |   | (15,000      | ) |   | -        |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Common stock issued at $0.21 including                  |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|warrants                                                | 5,476,190    |  |   | 5,476      |  |   | 487,381   |  |   | -            |   |   | -            |   |   | 657,143  |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Common stock issued at $0.21 including                  |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|warrants less expenses of $3,231                        | 566,833      |  |   | 567        |  |   | 36,369    |  |   | -            |   |   | -            |   |   | 78,869   |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Stock issued for exercise of options at $0.22 per share |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|in lieu of consulting fees                              | 50,000       |  |   | 50         |  |   | 10,950    |  |   | -            |   |   | -            |   |   | -        |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Stock issued for deferred offering costs                | 1,300,000    |  |   | 1,300      |  |   | 388,700   |  |   | -            |   |   | -            |   |   | -        |  |   | -           |  
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Net loss for period ended                               |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|June 30, 2004                                           | -            |  |   | -          |  |   | -         |  |   | -            |   |   | -            |   |   | -        |  |   | (1,015,433  | )
|                                                        |              |  |   |            |  |   |           |  |   |              |   |   |              |   |   |          |  |   |             |  
|Balance, June 30, 2004 (unaudited)                      | 161,540,148  |  | $ | 161,540    |  | $ | 2,646,802 |  | $ | (53,598      | ) | $ | (15,000      | ) | $ | 935,241  |  | $ | (3,637,843  | )

The accompanying condensed notes are an integral part of these
  financial statements.

F-4

---

EYI INDUSTRIES, INC.CONSOLIDATED STATEMENTS OF CASH FLOWS

|                                                                   |   | Six Months Ended |  
|------------------------------------------------------------------ | - | ---------------- | -
|                                                                   |   | June 30, 2004    |  
|                                                                   |   | (Unaudited)      |  
|                                                                   |   |                  |  
|CASH FLOWS PROVIDED (USED) BY OPERATING ACTIVITIES                 |   |                  |  
|Net loss                                                           | $ | (1,015,433       | )
|Loss allocated to minority interest                                |   | 15,998           |  
|                                                                   |   | (1,031,431       | )
|Adjustments to reconcile net loss                                  |   |                  |  
|to net
      cash used by operating activities:                    |   |                  |  
|Depreciation
      and amortization                                |   | 50,493           |  
|Decrease
      (increase) in:                                      |   |                  |  
|Related party receivables                                          |   | 470              |  
|Accounts receivable                                                |   | 13,804           |  
|Prepaid expenses                                                   |   | (370,341         | )
|Inventory                                                          |   | 46,049           |  
|Increase
      (decrease) in:                                      |   |                  |  
|Accounts payable and accrued liabilities                           |   | (117,129         | )
|Accounts payable - related parties                                 |   | 43,422           |  
|Customer deposits                                                  |   | -                |  
|Net cash used by operating activities                              |   | (1,364,663       | )
|                                                                  
|CASH FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES                 |   |                  |  
|Decrease (increase) in restricted cash                             |   | 13,368           |  
|Reimbursement of previously purchased asset                        |   | -                |  
|Purchase of trademarks and formulas                                |   | -                |  
|Increase in security deposit                                       |   | -                |  
|Net cash provided by investing activities                          |   | 13,368           |  
|                                                                  
|CASH FLOWS PROVIDED (USED) BY FINANCING ACTIVITIES                 |   |                  |  
|Net change in bank indebtedness                                    |   | (217,158         | )
|Issuance of stock, net of private placement
      costs & warrants |   | 1,576,902        |  
|Net cash provided by financing activities                          |   | 1,359,744        |  
|                                                                  
|Net increase in cash and cash equivalents                          |   | 8,449            |  
|                                                                  
|CASH - Beginning of Year                                           |   | 52,075           |  
|                                                                  
|CASH - End of Period                                               | $ | 60,524           |  
|                                                                  
|SUPPLEMENTAL CASH FLOW DISCLOSURES:                                |   |                  |  
|Interest expense paid                                              | $ | 33,991           |  
|Income taxes paid                                                  | $ | -                |  
|                                                                  
|NON-CASH INVESTING AND FINANCING TRANSACTIONS:                     |   |                  |  
|Stock issued for options exercised in lieu
      of debt           | $ | 528,000          |  
|Stock issued for options exercised in lieu
      of legal fees     | $ | 60,000           |  
|Stock subscription issued for promissory note                      | $ | 15,000           |  
|Stock issued for options exercised in lieu
      of legal fees     | $ | 11,000           |  
|Warrants issued for prepaid expenses                               | $ | 657,143          |  
|Stock issued for deferred offering costs                           | $ | 390,000          |  

The accompanying condensed notes are an integral part of these
  financial statements.

F-5

---

EYI INDUSTRIES, INC.CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
  June 30, 2004

NOTE 1  DESCRIPTION OF BUSINESS

Essentially Yours Industries, Inc., was incorporated on June
  21, 2002 in the State of Nevada. The main business activities of Essentially
  Yours Industries, Inc. were acquired through a merger with the former entity,
  Burrard Capital, Inc., and other entities concerning the reorganization of Essentially
  Yours Industries, Inc. On December 31, 2003, Essentially Yours Industries, Inc.
  entered into a share exchange agreement of its stock with Safe ID Corporation
  ("Safe ID"). This transaction is being accounted for as a share exchange and
  recapitalization. As a result of this transaction, Safe ID has changed its name
  to EYI Industries, Inc. ("the Company"), and is acting as the parent holding
  company for the operating subsidiaries.

The principal business of the Company is the marketing of
  health and wellness care products. The Company sells its products through network
  marketing distributors, which in turn, sell the products to the end customers.
  The Company maintains its principal business office in Surrey, British Columbia.
  Effective for the period ended December 31, 2003, the Company has elected to
  change its year-end from June 30 to December 31.

The Company has five wholly owned subsidiaries. The first
  subsidiary is Essentially Yours Industries, Inc. ("EYII"), incorporated on June
  21, 2002 in the state of Nevada. The secondary subsidiary is Halo Distributions
  LLC (hereinafter Halo), which was organized on January 15, 1999, in the State
  of Kentucky. Halo is the distribution center for the Company's product in addition
  to other products. The third subsidiary is RGM International Inc., which was
  incorporated on July 3, 1997, in the State of Nevada. RGM International Inc.
  is a dormant investment company, which owns 1 percent of Halo. The fourth subsidiary
  is Essentially Yours Industries (Canada) Inc. (hereinafter "EYI Canada"), which
  was organized on September 13, 2002, in the province of British Columbia, Canada.
  EYI Canada markets health and wellness care products for use in Canada. The
  fifth subsidiary is 642706 B.C. Ltd., doing business as EYI Management, which
  was organized on February 22, 2002, in the province of British Columbia, Canada.
  EYI Management provides accounting and marketing services to the consolidated
  entity.

Basis of Presentation

The accompanying interim condensed financial statements are
  prepared in accordance with rules set forth in Regulation SB of the Securities
  and Exchange Commission. As said, these statements do not include all disclosures
  required under generally accepted principles and should be read in conjunction
  with the audited financial statements for the year ended December 31, 2003.
  In the opinion of management, all required adjustments which consist of normal
  re-occurring accruals have been made to the financial statements.

F-6

---

EYI INDUSTRIES, INC.CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
  June 30, 2004

NOTE 2  SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES

Recent Accounting Pronouncements

In May 2003, the Financial Account Standards Board issued
  Statement of Financial Accounting Standards No. 150, "Accounting for Certain
  Financial Instruments with Characteristics of Both Liabilities and Equity" (hereinafter
  "SFAS No. 150"). SFAS No. 150 establishes standards for classifying and measuring
  certain financial instruments with characteristics of both liabilities and equity
  and requires that those instruments be classified as liabilities in statements
  of financial position. Previously, many of those instruments were classified
  as equity. SFAS No. 150 is effective for financial instruments entered into
  or modified after May 31, 2003 and otherwise is effective at the beginning of
  the first interim period beginning after June 15, 2003. The Company has determined
  that there was no impact from the adoption of the statement.

Restricted Cash

Restricted cash includes deposits held in a reserve account
  in the amount of $210,314 and $223,682 at June 30, 2004 and December 31, 2003,
  respectively. Such deposits are required by the bank as protection against unfunded
  charge backs and returns of credit card transactions.

Going Concern

As shown in the accompanying financial statements, the Company
  had negative working capital of approximately $12,000 and an accumulated deficit
  of approximately $3,600,000 incurred through June 30, 2004. These factors which
  raise substantial doubt about the Company's ability to continue as a going concern.
  The financial statements do not include any adjustments relating to the recoverability
  and classification of recorded assets, or the amounts and classification of
  liabilities that might be necessary in the event the Company cannot continue
  in existence.

Management has established plans designed to increase the
  sales of the Company's products, and decrease debt. The Company plans on continuing
  to reduce expenses, and with small gains in any combination of network sales,
  direct sales, international sales, and warehouse sales, believe that they will
  eventually be able to reverse the present deficit. Management intends to seek
  additional capital from new equity securities offerings that will provide funds
  needed to increase liquidity, fund internal growth and fully implement its business
  plan. Management plans include negotiations to convert significant portions
  of existing debt into equity.

The timing and amount of capital requirements will depend
  on a number of factors, including demand for products and services and the availability
  of opportunities for international expansion through affiliations and other
  business relationships.

F-7

---

EYI INDUSTRIES, INC.CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
  June 30, 2004

NOTE 3 PROPERTY AND EQUIPMENT

Capital assets are recorded at cost. Depreciation is calculated
  using the straight-line method over three to seven years.

NOTE 4  LOANS PAYABLE

On June 22, 2004, the Company entered into a loan agreement
  with Cornell Capital Partners, LP ("the Investor") in which the Company received
  $250,000 in funding in exchange for convertible securities guaranteed by the
  assets of the Company. The convertible debt instrument underlying this loan
  agreement will automatically convert into common stock by the second anniversary
  date of issuance. Failure to issue unrestricted, freely tradable common stock
  to the Investor upon conversion after the registration statement filed pursuant
  to this transaction has been declared effective would be considered an event
  of default, thereby entitling the Investor to accelerate full repayment of the
  convertible securities then outstanding. Under the agreement, the Company is
  required to keep available common stock duly authorized for issuance in satisfaction
  of convertible securities. See Note 7.

NOTE 5  CAPITAL STOCK

On April 6, 2004, an employee of the Company exercised 1,000,000
  options at $0.165 per share at the aggregate exercise price of $165,000. The
  options were paid by a combination of cash and a promissory note issued by the
  employee to the Company in the amount of $15,000. The note has been determined
  to be a stock subscription and has been properly allocated on the financial
  statements as a subscription receivable.

On April 20, 2004, an officer of the Company exercised 3,200,000
  options at $0.165 per share at the aggregate exercise price of $528,000. The
  options were paid in the form of foregone debt owed to the officer by the Company.
  See Note 9.

On May 4, 2004 we issued 5,476,190 common shares to Eyewonder,
  Inc. ("Eyewonder"), pursuant to the terms of the Letter Agreement dated May
  4, 2004. Eyewonder Inc. also received 5,476,190 warrants exercisable at a price
  of $0.30 per share for a period of five years from the date of issuance. In
  addition, on execution of the agreement, we agreed to issue options to purchase
  1,100,000 shares of our common stock at a price of $0.22 per share to certain
  individuals designated by Eyewonder.

On June 3, 2004, 300,000 options were exercised at $0.20 per
  share at the aggregate exercise price of $60,000. The options were paid in the
  form of forgone debt owed to the legal firm by the Company. The Company computed
  the number of options issued in this transaction based on the estimated fair
  market value of the Company's common stock on the dates of issuance.

F-8

---

EYI INDUSTRIES, INC.CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
  June 30, 2004

During the quarter ended June 30, 2004, the Company issued
  50,000 restricted shares at $0.22 per share in payment of consulting fees. The
  Company computed the number of shares issued in this transaction based on the
  fair value of services received and the market value of the Company's common
  stock on the dates of issuance.

During the quarter ended June 30, 2004, the Company received
  $115,805 from the private placement sale of 566,833 shares of common stock at
  $0.21 per share. In addition, the purchasers of the shares received warrants
  to purchase one additional share of common stock for each share purchased, exercisable
  at $0.30 per share, respectively, for a period of two years. See Note 6.

During the period ended June 30, 2004, the Company issued
  1,300,000 shares of its common stock as an incentive. See Note 7.

NOTE 6  COMMON STOCK WARRANTS

Financial Accounting Standards No. 123, "Accounting for Stock-Based
  Compensation" (hereinafter "SFAS No. 123"), defines a fair value-based method
  of accounting for stock options and other equity instruments. The Company has
  adopted this method, which measures compensation costs based on the estimated
  fair value of the award and recognizes that cost over the service period.

In accordance with SFAS No. 123, the fair value of stock options
  and warrants granted are estimated using the Black-Scholes Option Price Calculation.
  The following assumptions were made to value the warrants for the quarter ended
  June 30, 2004: risk-free interest rate of 4%, volatility of 110% and terms of
  two years.

Warrants 
  During the quarter ended June 30, 2004, the Company received $115,805 from the
  private placement sale of 566,833 shares of common stock. In addition, the purchasers
  of the shares received warrants to purchase one additional share of common stock
  for each share purchased, exercisable at $0.30 per share, respectively, for
  a period of two years. The fair value of the warrants issued as part of the
  private placement was determined to be $78,869.

NOTE 7  COMMITMENTS AND CONTINGENCIES

Purchase Agreement 
  On June 30, 2002, the Company entered into a distribution and license agreement
  with a company in which one of the Company's directors has an ownership interest.The agreement gives the Company the exclusive right to market, sell and
  distribute certain

F-9

---

EYI INDUSTRIES, INC.CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
  June 30, 2004

products for a five-year renewable term. Management estimates
  that 90% of the Company's sale volume results from products supplied under this
  licensing agreement.

During the quarter ended March 31, 2004, the Company negotiated
  the lowering of the purchasing threshold, and pursuant to the agreement, the
  Company is required to purchase the following amounts of product during the
  term of the agreement:

|June 1, 2003 to May 31, 2004 | $1,530,000
|---------------------------- | ----------
|                             |           
|June 1, 2004 to May 31, 2005 | $3,825,000

For each year thereafter, during the term of this agreement,
  the Company is obligated to purchase a minimum amount of $5,355,000 of product.

In the event that the Company is unavailable to meet the minimum
  purchase requirements of the licensing agreement or the terms requiring it to
  pay 15% of the difference between the minimum purchase amount referred to above
  and actual purchases for that year in which there is a shortfall, then the licensor
  has various remedies available to it including, renegotiating the agreement,
  removing exclusivity rights, or terminating the agreement.

As of the date of these financial statements, the licensor
  has not made any additional demands of the Company.

Lease Payments 
  The Company has operating lease commitments for its premises, office equipment
  and an automobile. The minimum annual lease commitments are as follows:

| | Year ended December 31, |  | Minimum  | 
| | ----------------------- |  | -------- | 
| |                         |  |          | 
| | 2004                    |  | $208,096 | 
| | 2005                    |  | 57,220   | 
| | 2006                    |  | 5,220    | 
| | 2007                    |  | 5,220    | 
| | 2008                    |  | 1,740    | 

Management Agreement 
  Essentially Yours Industries Corp. ("EYIC") has agreed to perform various services
  and administrative assistance to the Company on a month to month basis commencing
  April 1, 2004. The services and duties to be provided and performed by EYIC
  for EYII shall be determined and agreed upon by the parties, from time to time,
  as required, provided however, it is understood and agreed that such services
  will primarily consist of assisting EYII in the sales and marketing business.

The remuneration to be paid by EYII to EYIC for the aforementioned
  services shall be the cost of actual expenses plus a fee of five (5%) percent
  for services provided.

F-10

---

EYI INDUSTRIES, INC.CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
  June 30, 2004

Standby Equity Distribution Agreement 
  On June 22, 2004, the Company entered into a two-year Standby Equity Distribution
  Agreement with Cornell Capital Partners LP ("Cornell"). Pursuant to this agreement,
  Cornell will purchase up to 10,000,000 shares of the Company's common stock
  through a placement agent. The Company issued 1,300,000 shares of its common
  stock to Cornell and the placement agent upon the inception of this agreement.
  The $390,000 value of these shares is included in the deferred offering costs
  in the financial statements and will be amortized over the subsequent stock
  issuances under this agreement. Management will review these charges to revise
  any amortization based upon actual future issuances of common stock under this
  agreement. See Note 4.

Other Matters 
  The Company's predecessor organization, Essentially Yours Industries Corp.,
  a British Columbia corporation, has outstanding claims from the Internal Revenue
  Service for penalties and interest of approximately $2,000,000. Furthermore,
  one or more states may have claims against EYIC for unpaid state income taxes.
  Management believes that these claims are limited solely to EYIC and that any
  prospective unpaid tax claims against the Company are remote and unable to be
  estimated.

NOTE 8  CONCENTRATIONS

Economic Dependence 
  During 2004, the Company purchased approximately 90% of its products for resale
  from one company, Nutri-Diem Inc., which is the sole supplier of the Company's
  flagship product Calorad. Pursuant to a purchase agreement, the Company is subject
  to minimum purchases per annum. See Note 7.

NOTE 9  RELATED PARTY TRANSACTIONS

Accounts payable to related parties includes amounts due to
  the president and chief executive officer for services performed during the
  last year as well as to other related parties and the company with which they
  have a signed management agreement. These payables are non-interest bearing
  and non-collateralized.

During the year, the Company purchased approximately 90% of
  its products for resale from one company, Nutri-Diem Inc., which is owned in
  part by a director of the Company. See Note 7.

On April 7, 2004, an employee of the Company issued a promissory
  note in exchange for the exercise of options in the amount of $15,000. The note
  is due on demand and is payable with interest at the rate of 5% per annum. The
  note has been determined to be a stock subscription and is recorded on the Company's
  financial statements as a subscription receivable. See Note 5.

F-11

---

EYI INDUSTRIES, INC.CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
  June 30, 2004

During the period ending June 30, 2004, an agreement was reached
  between the president and an officer of the Company for the reallocation of
  related party payables. Subsequent to the agreement, the Company exchanged the
  debt owed the officer for the right of the officer to exercise 3,200,000 options
  at the exercise price of $0.16 per share for the aggregate exercise price of
  $528,000.

NOTE 10 - SUBSEQUENT EVENT

On July 2, 2004, the Company entered into two consulting services
  agreements in which the compensation will be in the form of 50,000 stock options
  per agreement which will allow the consultant to purchase shares at a purchase
  price of $0.26 per share for a term commencing July 2, 2004 and expiring July
  2, 2006. Under the related vesting schedule 50% of the options will vest on
  October 5, 2004 and the remaining 50% of the options will vest on October 5,
  2005.

On July 17, 2004, the Company signed a letter of intent regarding
  the purchase of all tangible and intangible assets of a Canadian corporation.
  The purchase price and terms of the transaction are to be mutually agreed upon
  by both parties upon completion of the due diligence inspection. In the event
  that the Company and the Canadian corporation have not entered into the definitive
  agreement by November 1, 2004, the arrangement will terminate and neither party
  will retain any obligation to the other party.

F-12

---

ITEM 2.              MANAGEMENT'S
  DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

FORWARD LOOKING STATEMENTS

The information in this discussion contains forward-looking
  statements within the meaning of Section 27A of the Securities Act of 1933,
  as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
  These forward-looking statements involve risks and uncertainties, including
  statements regarding EYI Industries, Inc.'s (the "Company") capital needs, business
  strategy and expectations. Any statements contained herein that are not statements
  of historical facts may be deemed to be forward-looking statements. In some
  cases, you can identify forward-looking statements by terminology such as "may",
  "should", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict",
  "potential" or "continue", the negative of such terms or other comparable terminology.
  Actual events or results may differ materially. In evaluating these statements,
  you should consider various factors, including the risks outlined in the Risk
  Factors section below, and, from time to time, in other reports the Company
  files with the Securities and Exchange Commission (the "SEC"). These factors
  may cause the Company's actual results to differ materially from any forward-looking
  statement. The Company disclaims any obligation to publicly update these statements,
  or disclose any difference between its actual results and those reflected in
  these statements. The information constitutes forward-looking statements within
  the meaning of the Private Securities Litigation Reform Act of 1995.

As used in this quarterly report, the terms "we", "us", "our",
  and "our company" mean EYI Industries, Inc. and its subsidiaries unless otherwise
  indicated. All dollar amounts in this quarterly report are in U.S. dollars unless
  otherwise stated.

OVERVIEW

We are in the business of selling, marketing, and distributing
  a product line consisting of approximately 34 nutritional products in two categories,
  dietary supplements and personal care products. Our most successful product
  is Calorad, a liquid collagen-based dietary supplement presently available on
  the market. These products are marketed through a network marketing program
  in which IBAs (Independent Business Associates) purchase products for resale
  to retail customers as well as for their own personal use. We have a list of
  over 400,000 IBAs, of which approximately 11,000 we consider "active". An "active"
  IBA is one who purchased our products within the preceding 12 months. Over 1,600
  of these IBAs are "very active", and are on our automatic Auto-ship Program.

The IBAs in our network are encouraged to recruit interested
  people to become new distributors of our products. New IBAs are placed beneath
  the recruiting IBA in the "network" and are referred to as being in that IBA's
  "down-line" organization. Our marketing plan is designed to provide incentives
  for IBAs to build, maintain and motivate an organization of recruited distributors
  in their down-line organization to maximize their earning potential. IBAs generate
  income by purchasing our products at wholesale prices and reselling them at
  retail prices. IBAs also earn commissions on product purchases generated by
  their down-line organization.

On an ongoing basis we review our product line for duplication
  and sales trends and make adjustments accordingly. As of June 30, 2004, our
  product line consisted of: (i) 23 dietary supplement products; and (ii) 11 personal
  care products consisting primarily of cosmetic and skin care products. Our products
  are primarily manufactured by Nutri-Diem, Inc., a related party, and sold by
  us under a license and distribution agreement with Nutri-Diem. Certain of our
  own products are manufactured for us by third party manufacturers pursuant to
  formulations developed for us. Our products are sold to our IBAs located in
  all 50 states, the District of Columbia and Canada.

We believe that our network marketing system is suited to
  marketing dietary supplement and personal care products, because sales of such
  products are strengthened by ongoing personal contact between IBAs and their
  customers. We also believe that our network marketing system appeals to a broad
  cross-section of people, particularly those looking to supplement family income
  or who are seeking part-time work. IBAs are given the opportunity, through our
  sponsored events and training sessions, to network with other distributors,
  develop selling skills and establish personal goals. We supplement monetary
  incentives with other forms of recognition, in order to motivate IBAs.

3

---

Recent Corporate Developments

We have experienced the following significant changes during our two most recently completed fiscal quarters:

|• | During the quarter ended
        June 30, 2004, we constructed and completed our first video-streaming
        ads and developed a Calorad customer training series of video-streams.
        We are prepared to share this video-streaming training model with our
        core Network channel. Additionally, both EyeWonder, Inc. and our internet
        web-marketing division have begun to test the ads in real time. In the
        next phase we intend to commence a sales initiative to capture sales,
        create brand awareness and support sales campaigns.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
|- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
|• | On June 22, 2004, we entered
        into a Standby Equity Distribution Agreement (the “Standby Equity
        Agreement”) with Cornell Capital Partners, LP (“Cornell”),
        pursuant to which we entered into, among other things, the following agreements
        with Cornell: Registration Rights Agreement, Securities Purchase Agreement,
        Escrow Agreement, Placement Agent Agreement and Investor Registration
        Rights Agreement. Pursuant to the terms of the Standby Equity Agreement,
        we may, at our discretion, periodically issue and sell shares of our common
        stock for a total purchase price of $10 million. If we request advances
        under the Standby Equity Agreement, Cornell will purchase shares of our
        common stock for 98% of the lowest volume weighted average price on the
        Over-the-Counter Bulletin Board or other principal market on which our
        common stock is traded for the 5 days immediately following the advance
        notice date. Cornell will retain 5% of each advance under the Standby
        Equity Agreement. We may not request advances in excess of a total of
        $10 million. The maximum of each advance is equal to $250,000. Upon execution
        of the Standby Equity Agreement, we agreed to pay a fee consisting of
        1,266,589 shares of our common stock (the “Cornell Fee Shares”)
        to Cornell, and a fee of 33,411 shares (the “Newbridge Fee Shares”)
        to Newbridge Securities Corporation (“Newbridge”) pursuant
        to a Placement Agent Agreement we entered into in connection with the
        Standby Equity Agreement. Pursuant to the terms of our Registration Rights
        Agreement and the Standby Equity Agreement with Cornell, we agreed to
        register and qualify the Fee Shares, the Newbridge Fee Shares and additional
        shares due to Cornell under the Standby Equity Agreement under a registration
        statement filed with the SEC.
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
|• | Also on June 22, 2004, we
        issued a 5% Secured Convertible Debenture (the “Secured Debenture”)
        to Cornell in the principal amount of $250,000. The Secured Debenture
        is convertible at Cornell’s option any time up to maturity at a
        conversion price equal to the lower of (i) 120% of the closing bid price
        of the common stock as of the date of issuance, or (ii) 80% of the average
        of the lowest daily volume weighted average price of our common stock
        for the 5 trading days immediately preceding the conversion date. At maturity,
        the remaining unpaid principal and accrued interest under the debenture
        shall be, at our option, either paid or converted into shares of common
        stock at the conversion price set out in the agreement. The Secured Debenture
        is secured by all of our assets. In the event the Secured Debenture is
        redeemed, then we will issue to Cornell a warrant to purchase 50,000 shares
        for every $100,000 redeemed at an exercise price of 120% of the closing
        bid price as of June 22, 2004. We agreed to register the resale of the
        amount of any principal owed which has been converted under the Secured
        Debenture pursuant to the terms of our Investor Registration Rights Agreement
        and Securities Purchase Agreement with Cornell.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
|• | In July, 2004 we entered
        into a letter of intent with a private Canadian company for the purpose
        of acquiring all of its assets (the "Assets") including a worldwide marketing
        and distribution license of certain products manufactured by Kawahara
        Co. Ltd. Of Japan. The letter of intent is subject to the consummation
        of a definitive agreement between the parties by November 1, 2004, and
        the completion of our due diligence review of the company's Assets. The
        purchase price for the Assets will be mutually agreed upon, upon completion
        of our due diligence inspections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
|• | On May 4, 2004 we entered
        into a letter agreement with Eyewonder, Inc. ("Eyewonder"), pursuant to
        which Eyewonder agreed to manage an advertising and lead generation campaign
        to promote and sell our products utilizing Eyewonder's proprietary audio-video
        streaming technology. In                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

4

---

|  | consideration
        of the services provided by Eyewonder under the agreement, we agreed to
        pay the following fees: a fee of $100,000 for product promotions, a fee
        of $770,000 for the implementation of a communications component for the
        campaign, and a fee of $140,000 for each consumer application. Under the
        terms of the agreement we have the option to pay fees to Eyewonder through
        the issuance to Eyewonder of units of our stock, each consisting one share
        at a price of $0.21 per share and one share purchase warrant exercisable
        at a price of $0.30 per share for a period of five years from the date
        of issuance. Eyewonder is also entitled to a fee of 8% of the gross revenue
        and 45% of the net revenue generated through all sales of products that
        result from responses to advertising by Eyewonder. In addition, on execution
        of the agreement, we agreed to issue options to purchase 1,100,000 shares
        of our common stock at a price of $0.22 per share to certain individuals
        designated by Eyewonder.
|- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
|• | On April 30, 2004 we entered into an amendment to our
        License and Distribution Agreement (the "LDA Agreement") dated June 30,
        2002 with Nutri-Diem Inc. ("Nutri-Diem"), lowering the amount of expenditures
        we are required to make under the LDA Agreement. Pursuant to the terms
        of the amendment to the LDA Agreement we are presently required to expend
        the following amounts on purchasing the products of Nutri-Diem over the
        term of the License and Distribution Agreement: (i) from June 1, 2003
        to May 31, 2004, $1,530,000, (ii) from June 1, 2004 to May 31, 2005, $3,825,000,
        and (iii) for each year thereafter, $5,355,000.                                                                                                                                                                                                                                                                                                                                                                                                                                       
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
|• | Our core business
        is in network marketing development and sales. In 2004 we implemented
        some critical changes to our network marketing development and sales strategy.
        We analyzed our compensation structure and realized that although the
        plan paid the sales force more than industry standard, it was still not
        encouraging sales, growth, duplication or retention. After months of study,
        outside consulting, field leader's focus groups and senior management
        discussion, we made key adjustments during our first fiscal quarter in
        2004 that are intended to cap the sales commission expense while at the
        same time promote increased network sales. We anticipate retaining a higher
        percentage of both customers and distributors with this new plan.                                                                                                                                                                                                                                                                                               
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
|• | To further facilitate
        growth and benefit from certain competitive advantages conferred by the
        new commission plan, we have upgraded our Internet support sites, created
        a trainer field certification program, developed a regional training program
        and increased our face to face training capability. These support tools
        are intended to ensure compliance, mature team and territory development
        and assist sales growth.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
|• | We see international
        sales as a key component for our growth in the next 5 years. During our
        second quarter of fiscal 2004, we entered into a joint venture agreement
        (the "JV Agreement") with World Wide Buyers' Club Inc. ("WWBC")
        and Supra Group, Inc. ("Supra Group"), dated as of May 28, 2004,
        for the purpose of jointly marketing and distributing our products through
        the existing Supra Group distribution system in the Latin American countries
        identified in the JV Agreement and the products of Supra Group using the
        existing EYI distribution system to residents in the U.S. We believe Supra
        Group has significant international experience, expertise and contacts
        and that this alliance will assist in our ability to expand into Spanish-speaking
        countries.                                                                                                                                                                                                                                                                    
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
|• | We also distribute
        our products through brick and mortar retail stores. We encourage and
        support our IBA's in placing our nutritional supplements in retail environments
        that include doctor's offices, spas, gyms, health food stores and pharmacies.
        We have recently upgraded our merchandising tools and believe that there
        is potential in continuing and expanding these sales.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

Our plan of operations over the next twelve months is to undertake the following:

|1. | We plan to expand the marketing of our Calorad product
        over the next twelve months. We feel that our main product Calorad, a
        21 year old market proven product, is positioned to expand into the weight
        loss industry.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

5

---

|2. | We intend to upgrade our computer systems over the
        next twelve months. These upgrades are intended to result in improved
        operational efficiency with the objective of reducing overhead costs.
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

RESULTS OF OPERATIONS

Net Sales

Net sales for six months ended June 30, 2004 was $3,494,932,
  compared to net sales of $6,974,710 during the comparative period in 2003. This
  represents a decline of $3,479,778 or 49.9%. Net sales for the three months
  ended June 30, 2004 were $1,965,737 compared to net sales of $2,775,506 during
  the comparative period in 2003, representing a decrease of $809,769 or 29.2%
  . The decrease in our net sales during the period ended June 30, 2004 was primarily
  the result of adjustments to our sales commission plan for our independent business
  associates ("IBAs") implemented during our first fiscal quarter in 2004 that
  were intended to cap the sales commission expenses.

For the six months ended June 30, 2004, the cost of goods
  sold was $2,176,014 compared to $4,761,924 for the comparative period in 2003.
  This represents a decline of $2,585,910 or 54.3%. For the three months ended
  June 30, 2004, the cost of goods sold was $1,343,919 compared to $1,750,595
  for the comparative period in 2003, representing a decrease of $406,676 or 23.2%
  . The decline in cost of goods sold during the period ended June 30, 2004 is
  attributed to the implementation of our new compensation plan for our IBAs.

Operating Expenses

Our operating expenses decreased to $2,373,826 during the
  six months ended June 30, 2004 compared to operating expenses of $3,000,261
  as at June 30, 2003. Our operating expenses during the three months ended June
  30, 2004 increased to $1,367,948 compared to operating expenses of $1,225,136
  during the three months ended June 30, 2003, representing an increase of $142,812
  or 11.7%. The increase of our operating expenses during the period ended June
  30, 2004 was primarily due to the increased telecommunications and advertising
  expenditures. Our operating expenses consist principally of salaries and other
  personnel costs for our administrative staff, rent, legal and professional fees,
  consulting fees, sales and marketing expenses and warehouse expenses.

Compensation Expense

For the
  six months ended June 30, 2004, compensation expense was $559,714 compared to
  $567,458 for the six months ended June 30, 2003. The increase in our compensation
  expense during the period is attributed to the hiring of additional customer
  service staff.

Net Loss

Our net
  loss for the six months ended June 30, 2004 increased to $1,015,433 from a net
  loss of $809,811 for the comparative period in 2003. Our net loss for the three
  months ended June 30, 2004 increased to $738,460 from a net loss of $188,665
  during the same period in 2003, representing an increase of $549,795 or 291%.
  The increased net loss for the period ended June 30, 2004 is primarily attributed
  to the decline in gross profit and increases to advertising and telecommunication
  expenses.



6

---

FINANCIAL CONDITION

Cash and Working Capital

We had
  cash of $60,524 as at June 30, 2004, compared with cash of $52,075 as at December
  31, 2003. Our working capital deficit decreased to $12,726 as at June 30, 2004,
  compared to a working capital deficit of $1,265,833 as at December 31, 2003.
  The decrease in our working capital deficit was primarily attributed to our
  agreement with Eyewonder during the quarter, pursuant to which we prepaid $770,000
  towards the communications component of the agreement.

Liabilities

The largest component of our working capital deficit are accounts
  payable and accrued liabilities in the amount of $1,542,411 as at June 30, 2004
  including amounts payable to related parties, compared to $1,616,118 as at December
  31, 2003.

Cash Used in Operating Activities

Cash used in operating activities for the six months ended
  June 30, 2004 was $1,364,663 compared to $605,346 for the comparative period
  in 2003, representing an increase of $759,317 or 125%. The increase in cash
  used in operating activities resulted from the increased net loss for the 2004
  period and the allocation of the technical component of our agreement with Eyewonder
  to prepaid expenses.

Cash Provided by Financing Activities

We have
  continued to finance our business primarily through private placement sales
  of our common stock, exercises of stock options, short term loans, conversion
  of accrued liabilities into stock and through increases in our accrued liabilities
  and accounts payable. Cash provided by financing activities for the six months
  ended June 30, 2004 was $1,359,744, compared to $51,704 for the six months ended
  June 30, 2003.

Financing
  activities included the issuance of common stock for aggregate proceeds of $1,359,744
  during the six months ended June 30, 2004 in private placement and other financing
  transactions. The private placement transactions included the issue of an aggregate
  of 566,833 shares of our common stock and associated share purchase warrants,
  representing an average price of $0.25 per share. During the three months ended
  June 30, 2004 we issued 4,200,000 and 300,000 shares upon exercise of options
  with an exercise price of $0.165 per share and $0.21 per share, respectively.
  All shares issued pursuant to stock option exercises during our first quarter
  were registered on Form S-8 registration statements that we filed with the SEC.
  During the three months ended June 30, 2004 we made the following issuances:
  50,000 restricted shares of our common stock at a price of $0.22 per share in
  payment of consulting fees to a consultant; 1,266,589 restricted shares of our
  common stock to Cornell in payment of certain fees owed to Cornell under the
  terms of the Standby Equity Agreement; and 33,411 restricted shares of our common
  stock to Newbridge under the terms of the Placement Agent Agreement.

Financing Requirements

Our consolidated
  interim financial statements included with this Quarterly Report on Form 10-QSB
  have been prepared assuming that we will continue as a going concern. As shown
  in the accompanying financial statements, we had negative working capital of
  approximately $12,726 and an accumulated deficit of approximately $3,637,843
  incurred through June 30, 2004.

Our current sources of working capital are sufficient to satisfy
  our anticipated working capital needs. In the event we do not receive further
  financing from our arrangements with Cornell, we will be required to seek additional
  financing to satisfy our anticipated working capital requirements. We may not
  be able to obtain additional working capital on acceptable terms, or at all.
  Accordingly, there is substantial doubt about our ability to continue as a going
  concern. We anticipate that any additional financing would be through the sales
  of our common or preferred stock or placement of convertible debt.

7

---

We presently do not have any arrangements in place for the
  sale of any of our securities and there is no assurance that we will be able
  to raise any additional capital that we require to continue operations. In the
  event that we are unable to raise additional financing on acceptable terms,
  then we may have to scale back our plan of operations and operating expenditures.
  We anticipate that we will continue to incur losses until such time as the revenues
  we are able to generate from sales and licensing of our products exceed our
  increased operating expenses. We base this expectation in part on the expectation
  that we will incur increased



operating expenses in completing our stated plan of operations
  and there is no assurance that we will generate revenues that exceed these expenses.

OFF-BALANCE SHEET ARRANGEMENTS

We have no off-balance sheet arrangements that have or are
  reasonably likely to have a current or future effect on our financial condition,
  changes in financial condition, revenues or expenses, results of operations,
  liquidity, capital expenditures or capital resources that are material to stockholders.

Critical Accounting Policies

The preparation of financial statements in conformity with
  accounting principles generally accepted in the United States requires our management
  to make estimates and assumptions that affect the reported amounts of assets
  and liabilities and disclosure of contingent assets and liabilities at the date
  of the financial statements and the reported amounts of revenues and expenses
  during the reporting periods. Actual results may differ from those estimates.

Our management routinely makes judgments and estimates about
  the effects of matters that are inherently uncertain. As the number of variables
  and assumptions affecting the probable future resolution of the uncertainties
  increase, these judgments become even more subjective and complex. We have identified
  certain accounting policies, described below, that are the most important to
  the portrayal of our current financial condition and results of operations.
  Our significant accounting policies are disclosed in Note 2 to our consolidated
  financial statements included in this quarterly report.

Property and Equipment

Property and equipment are stated at cost. Depreciation of
  property and equipment is calculated using the straight-line method over the
  estimated useful lives of the assets, which range from three to seven years.

Revenue Recognition

We recognize revenue from product sales upon shipment to IBAs,
  our customers. Revenue from administration fees is recognized upon collection
  from IBAs.

Long-lived Assets

We review the carrying amount of long-lived assets for impairment
  where events or changes in circumstances indicate that the carrying amount may
  not be recoverable. The determination of any impairment would include a comparison
  of estimated future cash flows anticipated to be generated during the remaining
  life of the assets to the net carrying value of the assets.

NEW ACCOUNTING PRONOUNCEMENTS

In May 2003, the Financial Account Standards Board issued
  Statement of Financial Accounting Standards No. 150, "Accounting for Certain
  Financial Instruments with Characteristics of Both Liabilities and Equity" (hereinafter
  "SFAS No. 150"). SFAS No. 150 establishes standards for classifying and measuring
  certain financial instruments with characteristics of both liabilities and equity
  and requires that those instruments be classified as liabilities in statements
  of financial position. Previously, many of those instruments were classified
  as equity. SFAS No. 150 is effective for financial instruments entered into
  or modified after May 31, 2003 and otherwise is effective at the beginning of
  the first interim period beginning after June 15, 2003. We have determined that
  there was no impact on us from the adoption of the statement.

8

---

RISK FACTORS

We
  have a limited operating history, an accumulated deficit and may have continued
  losses for the foreseeable future with no assurance of profitability. As
  of June 30, 2004 we had an accumulated deficit of $3,637,843. We will need to
  generate significant revenues to achieve profitability, which may not occur.
  We expect operating expenses to increase as a result of the further implementation
  of our business plan. Even if we achieve profitability, we may be unable to
  sustain or increase profitability on a quarterly or annual basis in the future.
  It is possible that we will never achieve profitability.

Management has established plans designed to attempt to increase
  the sales of our products, and decrease debt. We plan on continuing to reduce
  expenses, and with small gains in any combination of network sales, direct sales,
  international sales, and warehouse sales, believe that we will eventually be
  able to reverse the present deficit. Management intends to seek additional capital
  from new equity securities offerings that should provide funds needed to increase
  liquidity, and implement our business plan. Management’s plans include
  negotiations to convert portions of existing debt into equity.

The timing and amount of capital requirements will depend
  on a number of factors, including demand for products and services and the availability
  of opportunities for international expansion through affiliations and other
  business relationships.

We
  have a working capital deficit; we may need to raise additional capital to finance
  operations. We have relied on significant external financing to fund our
  operations. As of June 30, 2004, we had $60,524 of cash on hand and our total
  current assets were $1,578,754. Our current liabilities were $1,591,480. We
  will need to raise additional capital to fund our anticipated operating expenses
  and future expansion. Among other things, external financing may be required
  to cover our operating costs. Unless we obtain profitable operations, it is
  unlikely that we will be able to secure additional financing from external sources.
  If we are unable to secure additional financing or we cannot draw down on the
  Standby Equity Distribution Agreement, we believe that we will be required to
  seek additional financing to fund our continued operations. The sale of our
  common stock to raise capital may cause dilution to our existing shareholders.
  Our inability to obtain adequate financing will result in the need to curtail
  business operations. Any of these events would be materially harmful to our
  business and may result in a lower stock price. Our inability to obtain adequate
  financing will result in the need to curtail business operations and you could
  lose your entire investment. Our financial statements do not include any adjustments
  that might result from the outcome of this uncertainty.

Our
  independent auditors believe there is substantial doubt we can continue as a
  going concern.Our independent auditors believe there is substantial doubt
  that we can continue as a going concern which, if true, raises substantial doubt
  that a purchaser of our common stock will receive a return on his or her investment.
  As shown in the accompanying financial statements, we had negative working capital
  of approximately $12,726 and an accumulated deficit of approximately $3,637,843
  incurred through June 30, 2004, these factors raise substantial doubt about
  our ability to continue as a going concern.

We are dependent on our IBAs for our product marketing efforts.
  Our success and growth depend upon our ability to attract, retain and motivate
  our network of IBAs who market our products. IBAs are independent contractors
  who purchase products directly from us for resale and their own use. IBAs typically
  offer and sell our products on a part-time basis and may engage in other business
  activities, possibly including the sale of products offered by our competitors.
  Typically, we have non-exclusive arrangements with our IBAs which may be canceled
  on short notice and contain no minimum purchase requirements. While we encourage
  IBAs to focus on the purchase and sale of our products, they may give higher
  priority to other products, reducing their efforts devoted to marketing our
  products. Also, our ability to attract and retain IBAs could be negatively affected
  by adverse publicity relating to us, our products or our operations. In addition,
  as a result of our network marketing program, the down-line organizations headed
  by a relatively small number of key IBAs are responsible for a significant percentage
  of total sales.

The loss of a significant number of IBAs, including any key
  IBA, for any reason, could adversely affect our sales and operating results,
  and could impair our ability to attract new IBAs. There is no assurance that
  our network marketing program will continue to be successful or that we will
  be able to retain or expand our current network of IBAs.

Government regulation by the Food and Drug Administration
  and other federal and state entities of our products can impact our ability
  to market products. We market products that fall under two types of Food
  and Drug Administration regulations: dietary supplements and personal care products.
  In general, a dietary supplement:

|• | is a product (other than tobacco) that
        is intended to supplement the diet that bears or contains one or more
        of the following dietary ingredients: a vitamin, a mineral, a herb or
        other botanical, an amino acid, a dietary substance for use by man to
        supplement the diet by increasing the total daily intake, or a concentrate,
        metabolite, constituent, extract, or combinations of these ingredients.
|- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                     
|• | is intended for ingestion in pill, capsule,
        tablet, or liquid form.                                                                                                                                                                                                                                                                                                                                                                         
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                     
|• | is not represented for use as a conventional
        food or as the sole item of a meal or diet.                                                                                                                                                                                                                                                                                                                                                    
|  |                                                                                                                                                                                                                                                                                                                                                                                                                                                     
|• | is labeled as a "dietary supplement"
        .                                                                                                                                                                                                                                                                                                                                                                                                      

Personal care products are intended to be applied to the human
  body for cleansing, beautifying, promoting attractiveness, or altering the appearance
  without affecting the body's structure or functions. Included in this definition
  are products such as skin creams, lotions, perfumes, lipsticks, fingernail polishes,
  eye and facial make-up preparations, shampoos, permanent waves, hair colors,
  toothpastes, deodorants, and any material intended for use as a component of
  a cosmetic product. The Food & Drug Administration has a limited ability
  to regulate personal care products.

9

---

Dietary supplements must follow labeling guidelines outlined
  by the FDA. Neither dietary supplements nor personal care products require FDA
  or other government approval or notification to market in the United States.

Under the Dietary Supplement Health and Education Act of 1994,
  companies that manufacture and distribute dietary supplements are limited in
  the statements that they are permitted to make about nutritional support on
  the product label without FDA approval. In addition, a manufacturer of a dietary
  supplement must have substantiation for any such statement made and must not
  claim to diagnose, mitigate, treat, cure or prevent a specific disease or class
  of disease. The product label must also contain a prominent disclaimer. These
  restrictions may restrict our flexibility in marketing our product.

We believe that all of our existing and proposed products
  are dietary supplements or personal care products that do not require governmental
  approvals to market in the United States. Our key products are classified as
  follows:

Dietary Supplements

| | Calorad®           
|- | -------------------
|  |                    
| | Agrisept-L®        
|  |                    
| | Oxy-Up            
|  |                    
| | Triomin            
|  |                    
| | Noni Plus         
|  |                    
| | Iso-Greens        
|  |                    
| | Definition (drops)®
|  |                    
| | Essential Omega   

Personal Care Products

| | Definition (cream)®
|- | -------------------

The processing, formulation, packaging, labeling and advertising
  of such products, however, are subject to regulation by one or more federal
  agencies, including the FDA, the Federal Trade Commission, the Consumer Products
  Safety Commission, the Department of Agriculture and the Environmental Protection
  Agency. Our activities also are subject to regulation by various agencies of
  the states and localities in which our products are sold. Among other things,
  such regulation puts a burden on our ability to bring products to market. Any
  changes in the current regulatory environment could impose requirements that
  would make bringing new products to market more expensive or restrict the ways
  we can market our products.

No governmental agency or other third party makes a determination
  as to whether our products qualify as dietary supplements, personal care products
  or neither. We make this determination based on the ingredients contained in
  the products and the claims we make for the products.

If the Federal Trade Commission or certain states object
  to our product claims and advertising we may be forced to give refunds, pay
  damages, stop marketing certain products or change our business methods.The
  Federal Trade Commission and certain states regulate advertising, product claims,
  and other consumer matters, including advertising of our products. In the past
  several years the Federal Trade Commission has instituted enforcement actions
  against several dietary supplement companies for false or deceptive advertising
  of certain products. We provide no assurance that:

10

---

| | the Federal Trade Commission will not question our
      past or future advertising or other operations; or                     
|- | --------------------------------------------------------------------------------------------------------------------------------
|  |                                                                                                                                 
| | a state will not interpret product claims presumptively
      valid under federal law as illegal under that state's regulations.

Also, our IBAs and their customers may file actions on their
  own behalf, as a class or otherwise, and may file complaints with the Federal
  Trade Commission or state or local consumer affairs offices. These agencies
  may take action on their own initiative or on a referral from IBAs, consumers
  or others. If taken, such actions may result in:

| | entries of consent decrees;                                
|- | -----------------------------------------------------------
|  |                                                            
| | refunds of amounts paid by the complaining IBA or consumer;
|  |                                                            
| | refunds to an entire class of IBAs or customers;           
|  |                                                            
| | other damages; and                                         
|  |                                                            
| | changes in our method of doing business.                   

A complaint based on the activities of one IBA, whether
  or not such activities were authorized by us, could result in an order affecting
  some or all IBAs in a particular state, and an order in one state could influence
  courts or government agencies in other states. Proceedings resulting from
  these complaints may result in significant defense costs, settlement payments
  or judgments and could have a material adverse effect on us.

If our network marketing program is shown to violate federal
  or state regulations, we may be unable to market our products. Our network marketing
  program is subject to a number of federal and state laws and regulations administered
  by the Federal Trade Commission and various state agencies. These laws and regulations
  include securities, franchise investment, business opportunity and criminal
  laws prohibiting the use of "pyramid" or "endless chain" types of selling organizations.
  These regulations are generally directed at ensuring that product sales are
  ultimately made to consumers (as opposed to other IBAs) and that advancement
  within the network marketing program is based on sales of products, rather than
  investment in the company or other non-retail sales related criteria.

The compensation structure of a network marketing organization
  is very complex. Compliance with all of the applicable regulations and laws
  is uncertain because of:

| | the evolving interpretations of existing laws and
      regulations, and                                                          
|- | ----------------------------------------------------------------------------------------------------------------------------------
|  |                                                                                                                                   
| | the enactment of new laws and regulations pertaining
      in general to network marketing organizations and product distribution.

We have not obtained any no-action letters or advance rulings
  from any federal or state securities regulator or other governmental agency
  concerning the legality of our operations. Also, we are not relying on a formal
  opinion of counsel to such effect. Accordingly there is the risk that our network
  marketing system could be found to be in noncompliance with applicable laws
  and regulations, which could have a material adverse effect on us. Such a decision
  could require modification of our network marketing program, result in negative
  publicity, or have a negative effect on IBA morale and loyalty. In addition,
  our network marketing system will be subject to regulations in foreign markets
  administered by foreign agencies should we expand our network marketing organization
  into such markets.

The legality of our network marketing program is subject
  to challenge by our IBAs. We are subject to the risk of challenges to the
  legality of our network marketing organization by our IBAs, both individually
  and as a class. Generally, such challenges would be based on claims that our
  network marketing program was operated as an illegal "pyramid scheme" in violation
  of federal securities laws, state unfair practice and fraud

11

---

laws and the Racketeer Influenced and Corrupt Organizations
  Act. An illegal pyramid scheme is generally a marketing scheme that promotes
  "inventory loading" and does not encourage retail sales of the products and
  services to ultimate consumers. Inventory loading occurs when distributors purchase
  large quantities of non-returnable inventory to obtain the full amount of compensation
  available under the network marketing program. In the event of challenges to
  the legality of our network marketing organization by our IBAs, there is no
  assurance that we will be able to demonstrate that:

| |  | our network marketing policies were enforced, and                                                                                                                               
| | - | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |   |                                                                                                                                                                                 
| |  | the network marketing program and IBAs' compensation
      thereunder serve as safeguards to deter inventory loading and encourage
      retail sales to the ultimate consumers.

Proceedings resulting from these claims could result in
  significant defense costs, settlement payments or judgments, and could have
  a material adverse effect on us. One of our competitors, Nutrition for Life
  International, Inc., a multi-level seller of personal care and nutritional supplements,
  announced in 1999 that it had settled class action litigation brought by distributors
  alleging fraud in connection with the operation of a pyramid scheme. Nutrition
  for Life International agreed to pay in excess of $3 million to settle claims
  brought on behalf of its distributors and certain purchasers of its stock.

We believe that our marketing program is significantly different
  from the program allegedly promoted by Nutrition for Life International and
  that our marketing program is not in violation of anti-pyramid laws or regulations.
  However, there can be no assurance that claims similar to the claims brought
  against Nutrition for Life International and other multi-level marketing organizations
  will not be made against us, or that we would prevail in the event any such
  claims were made. Furthermore, even if we were successful in defending against
  any such claims, the costs of conducting such a defense, both in dollars spent
  and in management time, could be material and adversely affect our operating
  results and financial condition. In addition, the negative publicity of such
  a suit could adversely affect our sales and ability to attract and retain IBAs.

A large portion of our sales is attributable to Calorad.
  A significant portion of our net sales is expected to be dependent upon our
  Calorad product. Calorad has traditionally represented more than 90% of our
  net sales and, although we hope to expand and diversify our product offerings,
  Calorad is expected to provide a large portion of our net sales in the foreseeable
  future. If Calorad loses market share or loses favor in the marketplace, our
  financial results will suffer.

Our products are subject to obsolescence. The introduction
  by us or our competitors of new dietary supplement or personal care products
  offering increased functionality or enhanced results may render our existing
  products obsolete and unmarketable. Therefore, our ability to successfully introduce
  new products into the market on a timely basis and achieve acceptable levels
  of sales has and will continue to be a significant factor in our ability to
  grow and remain competitive and profitable. In addition, the nature and mix
  of our products are important factors in attracting and maintaining our network
  of IBAs, which consequently affects demand for our products. Although we seek
  to introduce additional products, the success of new products is subject to
  a number of conditions, including customer acceptance. There can be no assurance
  that:

| | our efforts to develop innovative new products will be successful,           
|- | -----------------------------------------------------------------------------
|  |                                                                              
| | customers will accept new products, or                                       
|  |                                                                              
| | that we will obtain required regulatory approvals of such
      new products.

In addition, no assurance can be given that new products currently
  experiencing strong popularity will maintain their sales over time. In the event
  we are unable to successfully increase the product mix and maintain competitive
  product replacements or enhancements in a timely manner in response to the introduction
  of new products, competitive or otherwise, our sales and earnings will be materially
  and adversely affected.

We have no manufacturing capabilities and we are dependent
  upon Nutri-Diem, Inc. and other companies to manufacture our products. We
  have no manufacturing facilities and have no present intention to manufacture
  any of our dietary supplement and personal care products. We are dependent upon

12

---

relationships with independent manufacturers to fulfill our
  product needs. Nutri-Diem, Inc., a related party, manufactures and supplies
  more than 70% of our products. We have contracts with Nutri-Diem that require
  us to purchase set amounts of its manufactured products for at least the next
  five years and possibly the next ten years. It is possible that these contracts
  with Nutri-Diem, Inc. could become unfavorable, and we may not be able to use
  other manufacturers to provide us with these services if our terms with Nutri-Diem,
  Inc. become unfavorable. In addition, we must be able to obtain our dietary
  supplement and personal care products at a cost that permits us to charge a
  price acceptable to the customer, while also accommodating distribution costs
  and third party sales compensation. Competitors who do own their own manufacturing
  may have an advantage over us with respect to pricing, availability of product
  and in other areas through their control of the manufacturing process.

We may not be able to deliver various products to our customers
  if third party providers fail to provide necessary ingredients to us. We are
  dependent on various third parties for various ingredients for our products.
  Some of the third parties that provide ingredients to us have a limited operating
  history and are themselves dependent on reliable delivery of products from others.
  As a result, our ability to deliver various products to our users may be adversely
  affected by the failure of these third parties to provide reliable various ingredients
  for our products.

We are materially dependent upon our key personnel and
  the loss of such key personnel could result in delays in the implementation
  of our business plan or business failure. We depend upon the continued involvement
  of Jay Sargeant, our President, Chief Executive Officer and Director, and Dori
  O'Neill, our Executive Vice President, Chief Operations Officer, Secretary,
  Treasurer and Director. As we are a developing company, the further implementation
  of our business plan is dependent on the entrepreneurial skills and direction
  of management. Mr. Sargeant, Mr. O'Neill guide and direct our activity and vision.
  This direction requires an awareness of the market, the competition, current
  and future markets and technologies that would allow us to continue our operations.
  The loss or lack of availability of these individuals could materially adversely
  affect our business and operations. We do not carry "key person" life insurance
  for these officers and directors, and we would be adversely affected by the
  loss of these two key employees.

We face substantial competition in the dietary supplement
  and personal care industry, including products that compete directly with Calorad.
  The dietary supplement and personal care industry is highly competitive. It
  is relatively easy for new companies to enter the industry due to the availability
  of numerous contract manufacturers, a ready availability of natural ingredients
  and a relatively relaxed regulatory environment. Numerous companies compete
  with us in the development, manufacture and marketing of supplements as their
  sole or principal business. Generally, these companies are well funded and sophisticated
  in their marketing approaches.

Depending on the product category, our competition varies.
  Calorad competes directly with Colvera, a product with different ingredients
  but a similar concept. Additionally, Calorad competes indirectly with food plans
  such as Weight Watchers and meal replacement products such as Slim Fast. Our
  Noni Plus product competes with Morinda and others. Our other products have
  similar well-funded and sophisticated competitors. Increased competitive activity
  from such companies could make it more difficult for us to increase or keep
  market share, since such companies have greater financial and other resources
  available to them and possess far more extensive manufacturing, distribution
  and marketing capabilities.

We may be subject to products liability claims and may
  not have adequate insurance to cover such claims. As with other retailers, distributors
  and manufacturers of products that are designed to be ingested, we face an inherent
  risk of exposure to product liability claims in the event that the use of our
  products results in injury. With respect to product liability claims, we
  have coverage of $5,000,000 per occurrence and $5,000,000 in the aggregate.
  Because our policies are purchased on a year to year basis, industry conditions
  or our own claims experience could make it difficult for us to secure the necessary
  insurance at a reasonable cost. In addition, we may not be able to secure insurance
  that will be adequate to cover liabilities. We generally do not obtain contractual
  indemnification from parties supplying raw materials or marketing our products.
  In any event, any such indemnification is limited by its terms and, as a practical
  matter, to the creditworthiness of the other party. In the event that we do
  not have adequate insurance or contractual indemnification, liabilities relating
  to defective products could require us to pay the injured parties' damages which
  are significant compared to our net worth or revenues.

13

---

We may be adversely affected by unfavorable publicity relating
  to our products or similar products manufactured by our competitors.We
  believe that the dietary supplement products market is affected by national
  media attention regarding the consumption of these products. Future scientific
  research or publicity may be unfavorable to the dietary supplement products
  market generally or to any particular product and may be inconsistent with earlier
  favorable research or publicity. Adverse publicity associated with illness or
  other adverse effects resulting from the consumption of products distributed
  by other companies, which are similar to our products, could reduce consumer
  demand for our products and consequently our revenues. This may occur even if
  the publicity did not relate to our products. Adverse publicity directly concerning
  our products could be expected to have an immediate negative effect on the market
  for that product.

Because we have few proprietary rights, others can provide
  products and services substantially equivalent to ours. We hold no patents.
  We believe that most of the technology used by us in the design and implementation
  of our products may be known and available to others. Consequently, others may
  be able to formulate products equivalent to ours. We rely on confidentiality
  agreements and trade secret laws to protect our confidential information. In
  addition, we restrict access to confidential information on a "need to know"
  basis. However, there can be no assurance that we will be able to maintain the
  confidentiality of our proprietary information. If our pending trademark or
  other proprietary rights are violated, or if a third party claims that we violate
  its trademark or other proprietary rights, we may be required to engage in litigation.
  Proprietary rights litigation tends to be costly and time consuming. Bringing
  or defending claims related to our proprietary rights may require us to redirect
  our human and monetary resources to address those claims.

Our common stock is "penny stock", with the result that
  trading of our common stock in any secondary market may be impeded. The
  SEC has adopted rules that regulate broker-dealer practices in connection with
  transactions in penny stocks. Penny stocks are generally equity securities with
  a price of less than $5.00, other than securities registered on certain national
  securities exchanges or quoted on the Nasdaq system, provided that current price
  and volume information with respect to transactions in such securities is provided
  by the exchange or system. The penny stock rules require a broker-dealer, prior
  to a transaction in a penny stock, to deliver a standardized risk disclosure
  document prepared by the Commission, that: (a) contains a description of the
  nature and level of risk in the market for penny stocks in both public offerings
  and secondary trading; (b) contains a description of the broker's or dealer's
  duties to the customer and of the rights and remedies available to the customer
  with respect to a violation to such duties or other requirements of Securities'
  laws; (c) contains a brief, clear, narrative description of a dealer market,
  including bid and ask prices for penny stocks and the significance of the spread
  between the bid and ask price; (d) contains a toll-free telephone number for
  inquiries on disciplinary actions; (e) defines significant terms in the disclosure
  document or in the conduct of trading in penny stocks; and (f) contains such
  other information and is in such form, including language, type, size and format,
  as the SEC may require by rule or regulation. The broker-dealer also must provide,
  prior to effecting any transaction in a penny stock, the customer with: (a)
  bid and offer quotations for the penny stock; (b) the compensation of the broker-dealer
  and its salesperson in the transaction; (c) the number of shares to which such
  bid and ask prices apply, or other comparable information relating to the depth
  and liquidity of the market for such stock; and (d) a monthly account statements
  showing the market value of each penny stock held in the customer's account.
  In addition, the penny stock rules require that prior to a transaction in a
  penny stock not otherwise exempt from those rules; the broker-dealer must make
  a special written determination that the penny stock is a suitable investment
  for the purchaser and receive the purchaser's written acknowledgment of the
  receipt of a risk disclosure statement, a written agreement to transactions
  involving penny stocks, and a signed and dated copy of a written suitability
  statement. These disclosure requirements may have the effect of reducing the
  trading activity in the secondary market for our stock as it is subject to these
  penny stock rules. Therefore, stockholders may have difficulty selling those
  securities.

14

---

ITEM 3.              CONTROLS
  AND PROCEDURES.

(A)     Evaluation Of Disclosure Controls And Procedures

As of the end of the period covered by this report, we carried
  out an evaluation, under the supervision and with the participation of our Principal
  Executive Officer and Principal Financial Officer, of the effectiveness of the
  design and operation of our disclosure controls and procedures. Our disclosure
  controls and procedures are designed to provide a reasonable level of assurance
  of achieving our disclosure control objectives. Our Principal Executive Officer
  and Principal Accounting Officer have concluded that our disclosure controls
  and procedures are, in fact, effective at this reasonable assurance level as
  of the period covered.

(B)     Changes In Internal Controls Over Financial
  Reporting

In connection with the evaluation of our internal controls
  during our last fiscal quarter, our Principal Executive Officer and Principal
  Financial Officer have determined that there are no changes to our internal
  controls over financial reporting that has materially affected, or is reasonably
  likely to materially effect, our internal controls over financial reporting.

15

---

PART II - OTHER INFORMATION

ITEM 1.              LEGAL
  PROCEEDINGS

Other than as described below, we are not a party to any material
  legal proceedings and to our knowledge, no such proceedings are threatened or
  contemplated.

1.     Oppression Action by Lavorato/Heyman

In 2002, an oppression action was commenced in the Supreme
  Court of British Columbia by the plaintiffs Brian Lavorato, Geraldine Heyman
  and their respective holding companies, alleging that Essentially Yours Industries
  Corp., our affiliate, had improperly vended assets into Essentially Yours Industries,
  Inc., our wholly owned subsidiary, as part of a corporate restructuring alleged
  to be oppressive to the plaintiffs. As of April 4, 2003, the lawsuit has been
  settled and was subsequently dismissed by the plaintiffs by consent, with the
  exception of claims asserted by the plaintiffs against Thomas K. Viccars, a
  former in-house counsel of Essentially Yours Industries, Corp., who may potentially
  assert a third party claim against Essentially Yours Industries, Inc.

2.     Action By Suhl, Harris and Babich

In 2003 a consolidated action was brought by the plaintiffs
  Wolf Suhl, Christine Harris and Edward Babich in the Supreme Court of British
  Columbia pursuant to an order pronounced in the New Westminster Registry under
  Action No. S061589 on May 7, 2003, which allowed the plaintiffs to proceed with
  an action against Essentially Yours Industries, Inc. The plaintiffs allege that
  Essentially Yours Industries, Inc. holds certain of its products or revenues
  derived therefrom as trust property for the benefit of the plaintiffs.

The claim is for an aggregate of 4.9% of the wholesale volume
  of sales generated by Essentially Yours Industries, Inc. from the alleged trust
  property, and for damages and costs. A consolidated statement of defence has
  been filed by Essentially Yours Industries, Inc., and interrogatories have been
  responded to. Management believes this claim to be without merit and intends
  to vigorously defend against this claim.

To the best of our knowledge, we are not subject to any other
  active or pending legal proceedings or claims against us or our subsidiaries
  or any of our properties that will have a material effect on our business or
  results of operations. However, from time to time, we may become subject to
  claims and litigation generally associated with any business venture.

ITEM 2.              CHANGES
  IN SECURITIES

During the three months ended June 30, 2004, we completed the
  sales of the following securities that were not registered pursuant to the Securities
  Act of 1933 (the “Securities Act”) and have not been reported on
  our previous Quarterly Reports on Form 10-QSB during the year:

|1. | During the quarter ended June 30, 2004 we issued
        50,000 shares of our common stock at a price of $0.22 per share to a consultant
        in respect of fees owed for certain consulting services provided to us
        by the consultant. All securities issued were endorsed with a restrictive
        legend confirming that the securities cannot be resold without registration
        under the Securities Act or an applicable exemption from the registration
        requirements of the Securities Act. The issuance was completed pursuant
        to Section 4(2) of the Securities Act on the basis that the consultant
        was a sophisticated investor.                                                                                                                                                                                                                                                                                                                                                      
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
|2. | During the quarter ended June 30, 2004, we issued
        5,476,190 units at a price of $0.21 per unit to Eyewonder in respect of
        certain amounts owed to Eyewonder under our Letter Agreement with Eyewonder.
        Each unit was comprised of one share of our common stock and one share
        purchase warrant entitling Eyewonder to purchase one share of our common
        stock at an exercise price of $0.30 per share for a period expiring May
        4, 2009. The issuance was completed pursuant to Section 4(2) of the Securities
        Act on the basis that Eyewonder was a sophisticated investor.                                                                                                                                                                                                                                                                                                                                                                                                       
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
|3. | As of June 7, 2004, we completed the sale of 136,548
        units at a price of $0.21 per unit for proceeds of $28,675 to seven investors.
        Each unit was comprised of one share of our common stock and one share
        purchase warrant. Each share purchase warrant entitles the holder to purchase
        one share of our common stock at a price of $0.30 per share for the three
        year period following closing. A total of 136,548 shares and 136,548 share
        purchase warrants were issued. The purchasers consisted of seven “accredited
        investors”, as defined by Rule 501 of Regulation D of the Securities
        Act. The sales were completed pursuant to Rule 506 of Regulation D of
        the Securities Act. All securities issued were endorsed with a restrictive
        legend confirming that the securities cannot be resold without registration
        under the Securities Act or an applicable exemption from the registration
        requirements of the Securities Act.
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
|4. | On June 22, 2004 we issued 1,266,589 and 33,411
        restricted shares of our common stock to Cornell and Newbridge, respectively
        in payment of certain fees owed to Cornell and Newbridge under the terms
        of the Standby Equity Agreement and the Placement Agent Agreement. All
        issuances were completed pursuant to Rule 506 of Regulation D of the Securities
        Act on the basis that Newbridge and Cornell are "accredited investors",
        as defined by Rule 501 of Regulation D of the Securities Act. All securities
        issued were endorsed with a restrictive legend confirming that the securities
        cannot be resold without registration under the Securities Act or an applicable
        exemption from the registration requirements of the Securities Act.                                                                                                                                                                                                               
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
|5. | On June 22, 2004, we issued a 5% Secured Convertible
        Debenture to Cornell in the principal amount of $250,000. Cornell purchased
        the Secured Debenture from us in a private placement on June 22, 2004.
        The sale of the Secured Debenture was completed pursuant to Rule 506 of
        Regulation D of the Securities Act. All securities to be issued pursuant
        to the Secured Debenture will be endorsed with a restrictive legend confirming
        that the securities cannot be resold without registration under the Securities
        Act or an applicable exemption from the registration requirements of the
        Securities Act.                                                                                                                                                                                                                                                                                                                                                           

16

---

ITEM 3.              DEFAULTS
  UPON SENIOR SECURITIES

None.

ITEM 4.              SUBMISSION
  OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matters were submitted to our security holders for a vote
  during the fiscal quarter ended June 30, 2004.

ITEM 5.              OTHER
  INFORMATION

None.

17

---

ITEM 6.              EXHIBITS
  AND REPORTS ON FORM 8-K.

EXHIBITS

(a)              Exhibits
  and Index of Exhibits

|Exhibit Number | Description of Exhibit                                                                                                                                                                                                                                                                
|-------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|3.1            | Articles of Incorporation.(1)                                                                                                                                                                                                                                                         
|3.2            | Bylaws.(1)                                                                                                                                                                                                                                                                            
|10.1           | Transfer/Assignment, dated
        as of May 27, 2002, between Essentially Yours Industries, Inc., a Nevada
        corporation and Essentially Yours Industries, Corp., a Canadian Federal
        Company. (1)                                                                      
|10.2           | License of Intellectual Property,
        dated as of June 30, 2002, between Essentially Yours Industries, Inc.,
        a Nevada corporation and Essentially Yours Industries, Corp., a Canadian
        Federal Company. (1)                                                        
|10.3           | Agency Appointment Agreement,
        dated as of June 30, 2002, between Essentially Yours Industries, Inc.,
        a Nevada corporation and Essentially Yours Industries, Corp., a Canadian
        Federal Company.(1)                                                             
|10.4           | Management Agreement, dated
        as of June 30, 2002, between Essentially Yours Industries, Inc., a Nevada
        corporation and Essentially Yours Industries, Corp., a Canadian Federal
        Company. (1)                                                                    
|10.5           | Distribution and License Agreement,
        dated as of June 30, 2002, between Essentially Yours Industries, Inc.,
        a Nevada corporation and Nutri-Diem, Inc., a Canadian corporation incorporated
        pursuant to the laws of the Quebec Company Act.(1)                  
|10.6           | Declaration of Trust, dated
        as of May 27, 2002, between Jay Sargeant and twelve named trust beneficiaries.(1)                                                                                                                                                                 
|10.7           | Notice to Transfer Intellectual
        Property Rights, dated as of August 28, 2002 from Essentially Yours Industries,
        Inc., a Nevada corporation, to Essentially Yours Industries, Corp., a
        Canadian Federal Company, and its directors. (1)                        
|10.8           | Assignment/Transfer of Intellectual
        Property Rights, dated as of August 28, 2002, from Essentially Yours Industries,
        Inc., a Nevada corporation, to Essentially Yours Industries, Corp., a
        Canadian Federal Company.(1)                                       
|10.9           | Consulting Agreement, dated
        as of November 5, 2002, between Essentially Yours Industries, Inc., a
        Nevada corporation, and Flaming Gorge, Inc. (1)                                                                                                                     
|10.10          | Consulting Agreement, dated
        as of November 5, 2002, between Essentially Yours Industries, Inc., a
        Nevada corporation, and O'Neill Enterprises, Inc.(1)                                                                                                                
|10.11          | Addendum to the Distribution
        and License Agreement dated as of November 7, 2002, between Essentially
        Yours Industries, Inc., a Nevada corporation and Nutri-Diem, Inc., a Canadian
        corporation incorporated pursuant to the laws of the Quebec Company Act.(1)
|10.12          | Form of Lock-up Agreement.(1)                                                                                                                                                                                                                                                         
|10.13          | Form of Subscription Documents.(1)                                                                                                                                                                                                                                                    
|10.14          | Form of IBA Application.(1)                                                                                                                                                                                                                                                           
|10.15          | Transfer/Assignment, dated
        as of May 27, 2002, between Essentially Yours Industries, Inc., a Nevada
        corporation and Essentially Yours Industries, Corp., a Canadian Federal
        Company.(1)                                                                       
|10.16          | Merger Agreement and Plan of
        Reorganization, dated as of June 30, 2002, between and among Burrard Capital,
        Inc., a Nevada corporation, Essentially Yours Industries, Inc., a Nevada
        corporation, and Jay Sargeant. (1)                                        
|10.17          | Share Exchange Agreement, dated
        November 4, 2002, by and among Safe ID Corporation, a Nevada corporation,
        Essentially Yours Industries, Inc., a Nevada corporation, the undersigned
        directors of Safe ID, and Jay Sargeant. (2)                               
|10.18          | First Amendment to Trust Agreement
        dated December 23, 2003, between Jay Sargeant and twelve named trust beneficiaries,
        revising the terms of the Declaration of Trust dated as of May 27, 2002,
        between Jay Sargeant and twelve named trust beneficiaries. (4)
|10.19          | Registration Rights Agreement,
        dated December 31, 2003, by and among Safe ID Corporation, A Nevada corporation,
        and certain shareholders of EYI Industries, Inc., A Nevada corporation.
        (2)                                                                   
|10.20          | Stock Compensation Program(3)                                                                                                                                                                                                                                                         
|10.21          | Consulting Agreement dated
        December 27, 2003 between Rajesh Raniga Inc. and Safe ID Corporation.(5)                                                                                                                                                                           
|10.22          | Consulting Agreement dated
        January 1, 2004 between EYI Industries, Inc. and O'Neill Enterprises Inc.
        (5)                                                                                                                                                              
|10.23          | Consulting Agreement dated
        January 1, 2004 between EYI Industries, Inc. and Flaming Gorge, Inc.(5)                                                                                                                                                                            

18

---

|10.24 | Addendum to the Distribution and License Agreement
      between Essentially Yours Industries, Inc. and Nutri-Diem Inc. dated April
      30, 2004.(5)           
|----- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------
|10.25 | Letter Agreement dated May 4, 2004 between Eye
      Wonder, Inc. and EYI Industries, Inc. (5)                                                                   
|10.26 | Standby Equity Distribution
      Agreement, dated June 22, 2004 by and between EYI Industries and Cornell
      Capital Partners, LP                            
|10.27 | Registration Rights
      Agreement, dated June 22, 2004 by and between EYI Industries and Cornell
      Capital Partners, LP                                    
|10.28 | Escrow Agreement,
      dated June 22, 2004 by and between EYI Industries and Cornell Capital Partners,
      LP                                                 
|10.29 | Placement Agent Agreement,
      dated June 22, 2004 by and between EYI Industries and Cornell Capital Partners,
      LP                                        
|10.30 | Securities Purchase
      Agreement, dated June 22, 2004 by and between EYI Industries and Cornell
      Capital Partners, LP                                    
|10.31 | Investor Registration
      Rights Agreement, dated June 22, 2004 by and between EYI Industries and
      Cornell Capital Partners, LP                           
|10.32 | Security Agreement,
      dated June 22, 2004 by and between EYI Industries and Cornell Capital Partners,
      LP                                               
|10.33 | Irrevocable Transfer
      Agent Instructions, dated June 22, 2004, by and among EYI Industries, Cornell
      Capital Partners, LP. and Corporate Stock Transfer
|10.34 | Escrow Agreement,
      dated June 22, 2004 by and among EYI Industries, Cornell Capital Partners,
      L.P. and Butler Gonzalez, LLP                           
|10.35 | Form of Secured Convertible
      Debenture                                                                                                                      
|14.1  | Code of Ethics (4)                                                                                                                                               
|21.1  | List of Subsidiaries (4)                                                                                                                                         
|31.1  | Certification of Chief
      Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                        
|31.2  | Certification of Chief
      Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                        
|32.1  | Certification of Chief
      Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant
      to Section 906 of the Sarbanes-Oxley Act of 2002    
|32.2  | Certification of Chief
      Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant
      to Section 906 of the Sarbanes-Oxley Act of 2002    

| | (1) | Filed as an exhibit to the registration statement on Form SB-2 of Essentially
      Yours Industries, Inc, filed with the SEC on November 12, 2002.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------
| | (2) | Filed as an exhibit to our Current Report on Form 8-K, filed with the
      SEC on January 8, 2004.                                                
| | (3) | Filed as an exhibit to our Registration Statement on Form S-8, filed
      with the SEC on March 30, 2004.                                         
| | (4) | Filed as an exhibit to our annual report on Form 10-KSB for the year
      ended December 31, 2003, filed with the SEC on April 14, 2004.          
| | (5) | Filed as an exhibit to our quarterly report on Form 10-QSB for the period
      ended March 31, 2004, filed with the SEC on May 24, 2004.          

REPORTS ON FORM 8-K

We filed the following current reports on Form 8-K during the fiscal quarter ended June 30, 2004.

|Date of Form 8-K or 8-K/A | Date of Filing with the SEC | Description of the Form 8-K                                                                                                                         
|------------------------- | --------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------
|June 15, 2004             | June 16, 2004               | Disclosure of
        entry into a joint venture agreement with World Wide Buyers' Club Inc.
        and Supra Group, Inc., dated as of May 28, 2004

We did not file any current reports on Form 8-K since June 30, 2004.

19

---

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act,
  the registrant has duly caused this report to be signed on its behalf by the
  undersigned, thereunto duly authorized.

EYI INDUSTRIES, INC.

|By: | /s/
      Jay Sargeant              | 
|--- | ----------------------------------- | 
|    | Jay Sargeant                        | 
|    | President, Chief Executive Officer, | 
|    | and Director                        | 
|    | (Principal Executive Officer)       | 
|    | Date:
      August 19, 2004         | 

---